MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock Price & Overview
NASDAQ:MRVI • US56600D1072
Current stock price
The current stock price of MRVI is 3.09 USD. Today MRVI is down by -0.64%. In the past month the price decreased by -13.2%. In the past year, price increased by 30.93%.
MRVI Key Statistics
- Market Cap
- 794.346M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.28
- Dividend Yield
- N/A
MRVI Stock Performance
MRVI Stock Chart
MRVI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to MRVI. When comparing the yearly performance of all stocks, MRVI is one of the better performing stocks in the market, outperforming 76.09% of all stocks.
MRVI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MRVI. The financial health of MRVI is average, but there are quite some concerns on its profitability.
MRVI Earnings
On February 25, 2026 MRVI reported an EPS of -0.04 and a revenue of 49.87M. The company beat EPS expectations (44.7% surprise) and missed revenue expectations (-0.32% surprise).
MRVI Forecast & Estimates
17 analysts have analysed MRVI and the average price target is 4.01 USD. This implies a price increase of 29.68% is expected in the next year compared to the current price of 3.09.
For the next year, analysts expect an EPS growth of 33.57% and a revenue growth 10.72% for MRVI
MRVI Groups
Sector & Classification
MRVI Financial Highlights
Over the last trailing twelve months MRVI reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS decreased by -180% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -16.97% | ||
| ROE | -61.58% | ||
| Debt/Equity | 1.49 |
MRVI Ownership
MRVI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 19.71 | 182.311B | ||
| DHR | DANAHER CORP | 22.15 | 132.341B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 130.38 | 43.422B | ||
| A | AGILENT TECHNOLOGIES INC | 16.96 | 31.928B | ||
| WAT | WATERS CORP | 20.68 | 29.658B | ||
| IQV | IQVIA HOLDINGS INC | 13.22 | 27.806B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.08 | 25.733B | ||
| ILMN | ILLUMINA INC | 23.78 | 19.296B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 30.62 | 17.805B | ||
| MEDP | MEDPACE HOLDINGS INC | 26.77 | 13.248B | ||
| RVTY | REVVITY INC | 15.8 | 9.821B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.359B | ||
| TECH | BIO-TECHNE CORP | 23.68 | 8.243B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MRVI
Company Profile
Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 435 full-time employees. The company went IPO on 2020-11-20. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. The company serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.
Company Info
IPO: 2020-11-20
MARAVAI LIFESCIENCES HLDGS-A
10770 Wateridge Circle Suite 200, Suite 200
San Diego CALIFORNIA 92121 US
CEO: Carl Hull
Employees: 435
Phone: 13026587581
MARAVAI LIFESCIENCES HLDGS-A / MRVI FAQ
What does MARAVAI LIFESCIENCES HLDGS-A do?
Maravai Lifesciences Holdings, Inc. is a life sciences company. The company is headquartered in San Diego, California and currently employs 435 full-time employees. The company went IPO on 2020-11-20. Its segments include Nucleic Acid Production Segment and Biologics Safety Testing Segment. The Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. This segment’s business units include TriLink Discovery, TriLink GMP, Glen Research and Alphazyme. The Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. This segment’s business is comprised of Cygnus Technologies. The company serves various companies, including biopharmaceutical, vaccine, diagnostics and cell and gene therapy.
What is the current price of MRVI stock?
The current stock price of MRVI is 3.09 USD. The price decreased by -0.64% in the last trading session.
What is the dividend status of MARAVAI LIFESCIENCES HLDGS-A?
MRVI does not pay a dividend.
What is the ChartMill rating of MARAVAI LIFESCIENCES HLDGS-A stock?
MRVI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does MARAVAI LIFESCIENCES HLDGS-A belong to?
MARAVAI LIFESCIENCES HLDGS-A (MRVI) operates in the Health Care sector and the Life Sciences Tools & Services industry.
Can you provide the PE ratio for MRVI stock?
MARAVAI LIFESCIENCES HLDGS-A (MRVI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
Can you provide the number of employees for MARAVAI LIFESCIENCES HLDGS-A?
MARAVAI LIFESCIENCES HLDGS-A (MRVI) currently has 435 employees.